Dr. James Crowe, MD

NPI: 1609968023
Total Payments
$106,449
2024 Payments
$4,564
Companies
11
Transactions
35

Payment Breakdown by Category

Consulting$85,239 (80.1%)
Travel$15,799 (14.8%)
Other$3,290 (3.1%)
Food & Beverage$1,121 (1.1%)
Research$1,000 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $85,239 11 80.1%
Travel and Lodging $15,799 16 14.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,290 1 3.1%
Food and Beverage $1,121 6 1.1%
Unspecified $1,000 1 0.9%

Payments by Type

General
$105,449
34 transactions
Research
$1,000
1 transactions

Top Paying Companies

Company Total Records Latest Year
Grifols, S.A. $51,103 1 $0 (2021)
GlaxoSmithKline, LLC. $11,872 3 $0 (2020)
Merck KGaA $11,022 4 $0 (2019)
PFIZER INC. $10,350 8 $0 (2017)
Regeneron Pharmaceuticals, Inc. $5,730 6 $0 (2017)
SANOFI-AVENTIS U.S. LLC $4,133 3 $0 (2022)
AstraZeneca Pharmaceuticals LP $3,960 1 $0 (2024)
Merck Sharp & Dohme LLC $3,560 2 $0 (2022)
BTG International, Inc. $2,655 3 $0 (2024)
Emergent BioSolutions Inc. $1,063 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,564 2 AstraZeneca Pharmaceuticals LP ($3,960)
2023 $2,051 2 BTG International, Inc. ($2,051)
2022 $5,958 4 SANOFI-AVENTIS U.S. LLC ($3,290)
2021 $52,803 2 Grifols, S.A. ($51,103)
2020 $12,872 4 GlaxoSmithKline, LLC. ($11,872)
2019 $11,277 5 Merck KGaA ($11,022)
2018 $43.45 1 SANOFI-AVENTIS U.S. LLC ($43.45)
2017 $16,880 15 PFIZER INC. ($10,350)

All Payment Transactions

35 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/13/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $3,960.00 General
01/25/2024 BTG International, Inc. Travel and Lodging Cash or cash equivalent $604.27 General
04/26/2023 BTG International, Inc. Food and Beverage In-kind items and services $51.06 General
02/23/2023 BTG International, Inc. Consulting Fee Cash or cash equivalent $2,000.00 General
08/24/2022 Emergent BioSolutions Inc. Consulting Fee Cash or cash equivalent $800.00 General
08/24/2022 Emergent BioSolutions Inc. Travel and Lodging Cash or cash equivalent $8.00 General
06/10/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,860.00 General
01/18/2022 SANOFI-AVENTIS U.S. LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,290.00 General
09/27/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,700.00 General
04/01/2021 Grifols, S.A. Consulting Fee Cash or cash equivalent $51,102.77 General
08/13/2020 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $9,686.17 General
08/13/2020 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $1,937.15 General
08/13/2020 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $249.15 General
05/04/2020 Eli Lilly and Company Cash or cash equivalent $1,000.00 Research
08/21/2019 Emergent BioSolutions Inc. Food and Beverage Cash or cash equivalent $255.23 General
07/09/2019 Merck KGaA Travel and Lodging In-kind items and services $10,507.74 General
07/09/2019 Merck KGaA Travel and Lodging In-kind items and services $251.88 General
07/09/2019 Merck KGaA Travel and Lodging In-kind items and services $193.68 General
07/09/2019 Merck KGaA Food and Beverage In-kind items and services $68.75 General
07/30/2018 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Food and Beverage In-kind items and services $43.45 General
10/30/2017 PFIZER INC. Travel and Lodging In-kind items and services $121.77 General
10/11/2017 PFIZER INC. Consulting Fee Cash or cash equivalent $4,000.00 General
10/04/2017 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Consulting Fee Cash or cash equivalent $800.00 General
08/14/2017 PFIZER INC. Consulting Fee Cash or cash equivalent $4,500.00 General
08/07/2017 PFIZER INC. Travel and Lodging In-kind items and services $68.56 General

About Dr. James Crowe, MD

Dr. James Crowe, MD is a Pediatric Infectious Diseases healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609968023.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Crowe, MD has received a total of $106,449 in payments from pharmaceutical and medical device companies, with $4,564 received in 2024. These payments were reported across 35 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($85,239).

Practice Information

  • Specialty Pediatric Infectious Diseases
  • Location Nashville, TN
  • Active Since 09/30/2006
  • Last Updated 03/29/2022
  • Taxonomy Code 2080P0208X
  • Entity Type Individual
  • NPI Number 1609968023

Products in Payments

  • NO PRODUCT DISCUSSED (Drug) $843.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Infectious Diseases Doctors in Nashville